Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Rich Pharmaceuticals, Inc. | rcha8k.htm |
September 14, 2017
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, DC 20549
We have read the statements of Rich Pharmaceuticals, Inc., pertaining to our firm included under Item 4.01 of Form 8-K dated September 5, 2017 and agree with such statements as they pertain to our firm.
Sincerely,
/s/ KLJ & Associates, LLP